CDAKQ — Codiak BioSciences,. Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.06m
- -$26.01m
- $22.94m
U.S. STOCKS ON THE MOVE-Energy firms, crypto stocks, Walt Disney
U.S. STOCKS ON THE MOVE-Cyclerion, banks, Jounce Therapeutics
U.S. STOCKS ON THE MOVE-Tesla, BrainStorm, Pinterest
Codiak BioSciences down after co files for Chapter 11 bankruptcy
COVID vaccine developer Codiak files for US bankruptcy protection (updated)
Brief: Codiak BioSciences To Pursue Asset Sale Through Voluntary Chapter 11 Process
Codiak BioSciences files for Chapter 11 bankruptcy protection
Codiak BioSciences, Inc. expected to post a loss of 34 cents a share - Earnings Preview
Codiak BioSciences, Inc. reports results for the quarter ended in September - Earnings Summary
Codiak BioSciences, Inc. expected to post a loss of 82 cents a share - Earnings Preview
Brief: Codiak Presents Preclinical Data Demonstrating Its Pan Beta-Coronavirus Vaccine Elicits Broad Protective Immunity Against Known Variants Of Sars-Cov-2 And Related Sarbecoviruses
Brief: Arch Venture Fund VIII Reports 24.7% Stake In Codiak Biosciences, As Of September 13
U.S. STOCKS ON THE MOVE-Akouos, Core & Main, Revance Therapeutics
U.S. STOCKS ON THE MOVE-Planet Labs, Catalyst Pharma, Akero
Codiak BioSciences down after pricing stock offer at discount
Brief: Codiak Biosciences Prices 13.3 Mln Shares And Accompanying Warrants At Combined Price Of $1.50/Share
Brief: Codiak Announces Proposed Public Offering Of Common Stock And Warrants
Codiak BioSciences plunges on stock-and-warrants deal
Codiak down after Goldman Sachs downgrades rating